Search Within

GSK Faculty

Formats
  1. Journal Article (13919)
  2. Meeting Abstract (7133)
  3. Review (524)
  4. Book Section (344)
  5. Editorial (314)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (46)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (24)
Groups
  1. Sloan Kettering Institute Faculty (11533)
  2. Department of Medicine (10622)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (8352)
  4. Tow Center for Developmental Oncology (TCDO) (7005)
  5. Sloan Kettering Institute Postdocs (6301)
  6. Solid Tumor Oncology Division (5929)

More Groups

People
  1. Marc Ladanyi (1332)
  2. Steven Larson (959)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (902)
  5. Kenneth Offit (791)
  6. Ross Levine (786)

More People

Years
  1. 2025 (432)
  2. 2024 (904)
  3. 2023 (1015)
  4. 2022 (1148)
  5. 2021 (1086)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1506)
  2. Journal of Clinical Oncology (1294)
  3. Cancer Research (1105)
  4. Clinical Cancer Research (529)
  5. Modern Pathology (497)
  6. Journal of Nuclear Medicine (476)

More Publications

Publishers
  1. Nature Publishing Group (2620)
  2. American Association for Cancer Research (2202)
  3. Elsevier Inc. (1938)
  4. American Society of Hematology (1590)
  5. Cell Press (1437)
  6. American Society of Clinical Oncology (1397)

More Publishers

Results (22632)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized double-blind phase 3 study of vorasidenib vs placebo in patients with mutant IDH1/2 diffuse glioma (INDIGO): Exploratory analysis of variant allele frequency and progression-free survival
    Meeting Abstract

    Cloughesy, T.; Mellinghoff, I.; van den Bent, M.; Blumenthal, D.; Touat, M.; Peters, K.; Clarke, J.; Mendez, J.; Yust-Katz, S.; Mason, W.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Phase 1 safety lead-in and randomized open-label perioperative study of vorasidenib combined with pembrolizumab in recurrent or progressive enhancing IDH1-mutant astrocytomas: Safety lead-in results
    Meeting Abstract

    Wen, P.; Peters, K.; de la Fuente, M.; Mellinghoff, I.; Arrillaga-Romany, I.; Kumthekar, P.; Clarke, J.; Puduvalli, V.; de Groot, J.; Zhang, X. M.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Prognostic implications of small cell lung cancer (SCLC) transcriptional subtyping for central nervous system (CNS) metastases
    Meeting Abstract

    Skakodub, A.; Tringale, K.; Egger, J.; Eichholz, J.; Yu, Y.; Gomez, D.; Rimner, A.; Li, B.; Yamada, Y.; Wilcox, J.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Public tumor-wide neoantigens derived from clonal aberrant splicing events drive tumor-specific T-cell responses
    Meeting Abstract

    Kwok, D.; Stevers, N.; Nejo, T.; Jung, J.; Chen, L.; Lakshmanachetty, S.; Etxeberria, I.; Gallus, M.; Yamamichi, A.; Ramos, E.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Results of safety lead in of phase IL trial of combination olaparib, temozolomide, and pembrolizumab for patients with IDH-mutant glioma
    Meeting Abstract

    Fortunato, J.; Newton, A.; Gonzalez, A.; Gavrilovic, I.; Miller, A.; Grommes, C.; Lin, A.; Pentsova, E.; Mellinghoff, I.; Kaley, T.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Droplet digital PCR enhances detection of hotspot mutations in circulating tumor DNA from cerebrospinal fluid of patients with high-grade glioma
    Meeting Abstract

    Tartaro, M.; Nandakumar, S.; Hertz, C. A.; Holle, B.; Hill, K.; Lapshina, M.; Farina, A.; Arcila, M.; Miller, A.; Mellinghoff, I.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Modeling reversible tumorigenesis in cerebral organoids
    Meeting Abstract

    Graham, M.; Codega, P.; Campos, C.; Nandakumar, S.; Rosenblum, M.; Antonescu, C.; Grogan, M.; Benhamida, J.; Bale, T.; von Deimling, A.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Evolving survival in patients with leptomeningeal metastases from solid tumors
    Meeting Abstract

    Chabot, K.; Osei-Gyening, I.; Estrera, R.; Yang, J.; Pentsova, E.; Boire, A.; Wilcox, J.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response
    Meeting Abstract

    Imber, B.; Ravichandran, V.; Rao, P.; Casanova, H.; Friend, J.; Simpson, J.; Pike, L.; Zinovoy, M.; Mitchell, R.; Chacko, C.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Artificial intelligence-based assessment of HER2-low expression on breast cancer H&E digital whole slide images
    Meeting Abstract

    Retamero, J.; Oakley, J.; Reis-Filho, J.; Horton, M.; Klimstra, D.
    Journal of Pathology (2023)

    Fulltext@MSK | Save